By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


KalVista Pharmaceuticals 

1 Venture Road
Southampton Science Park
  Southampton  SO16 7NP  United Kingdom
Phone: 44-23-8076-3480 Fax: 44-23-8076-6755



Company News
KalVista Pharmaceuticals Reports Fiscal Third Quarter Results 3/17/2017 8:09:13 AM
KalVista Pharmaceuticals Appoints Dr. Andreas Maetzel Senior Vice President Of Medical 3/9/2017 8:29:55 AM
KalVista Pharmaceuticals Appoints Edward P. Feener, Ph.D. As Chief Scientific Officer 11/29/2016 7:52:15 AM
KalVista Pharmaceuticals Announces Closing Of Merger With Carbylan 11/22/2016 6:55:52 AM
KalVista Pharmaceuticals Announces Initiation Of A Phase 1 Clinical Trial Of KVD818 For The Treatment Of Hereditary Angioedema 8/11/2016 7:29:58 AM
KalVista Pharmaceuticals To Support Global Conference Focused On Hereditary Angioedema 5/19/2016 10:11:38 AM
KalVista Pharmaceuticals Banks $33 Million 7/22/2015 6:27:10 AM
KalVista Pharmaceuticals Brings Expertise to New European Consortium Focused on the Discovery and Development of Novel Eye Therapeutics 9/25/2013 9:41:49 AM
KalVista Pharmaceuticals and JDRF Form Research Partnership Focused on Novel Approach for Treating Diabetic Eye Disease 1/9/2012 10:37:27 AM